136 related articles for article (PubMed ID: 32541941)
1. Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model.
Iwai T; Oebisu N; Hoshi M; Orita K; Yamamoto A; Hamamoto S; Kageyama K; Nakamura H
Sci Rep; 2020 Jun; 10(1):9679. PubMed ID: 32541941
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits.
Hamamoto S; Okuma T; Yamamoto A; Kageyama K; Takeshita T; Sakai Y; Nishida N; Matsuoka T; Miki Y
Radiology; 2013 May; 267(2):405-13. PubMed ID: 23440322
[TBL] [Abstract][Full Text] [Related]
3. In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation.
Nakagawa H; Mizukoshi E; Iida N; Terashima T; Kitahara M; Marukawa Y; Kitamura K; Nakamoto Y; Hiroishi K; Imawari M; Kaneko S
Cancer Immunol Immunother; 2014 Apr; 63(4):347-56. PubMed ID: 24384836
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of liver tumors in combination with local OK-432 injection prolongs survival and suppresses distant tumor growth in the rabbit model with intra- and extrahepatic VX2 tumors.
Kageyama K; Yamamoto A; Okuma T; Hamamoto S; Takeshita T; Sakai Y; Nishida N; Matsuoka T; Miki Y
Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1383-92. PubMed ID: 23737021
[TBL] [Abstract][Full Text] [Related]
5. Combination of intratumoural micellar paclitaxel with radiofrequency ablation: efficacy and toxicity in rodents.
Wu H; Fan ZP; Jiang AN; Di XS; He B; Wang S; Goldberg SN; Ahmed M; Zhang Q; Yang W
Eur Radiol; 2019 Nov; 29(11):6202-6210. PubMed ID: 30993436
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma.
Sun T; Sun B; Cao Y; Liu J; Chen J; Liang B; Zheng C; Kan X
Biomed Pharmacother; 2023 Oct; 166():115351. PubMed ID: 37625323
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation.
Homma S; Sagawa Y; Komita H; Koido S; Nagasaki E; Ryoma Y; Okamoto M
Cancer Immunol Immunother; 2007 Aug; 56(8):1265-74. PubMed ID: 17219148
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
Kawano M; Itonaga I; Iwasaki T; Tsumura H
Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency hyperthermia enhances the effect of OK-432 for Hepatocellular carcinoma by activating of TLR4-cGAS-STING pathway.
Sun B; Zhang Q; Sun T; Liu J; Cao Y; Liang B; Zheng C; Kan X
Int Immunopharmacol; 2024 Mar; 130():111769. PubMed ID: 38442584
[TBL] [Abstract][Full Text] [Related]
10. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer.
Li L; Wang W; Pan H; Ma G; Shi X; Xie H; Liu X; Ding Q; Zhou W; Wang S
J Transl Med; 2017 Jan; 15(1):23. PubMed ID: 28137271
[TBL] [Abstract][Full Text] [Related]
11. Effects of streptococcal preparation OK-432 on cytokine induction in spleen and tumour tissues of mice bearing MH-134 tumour cells.
Nakatani S; Iwagaki H; Okabayashi T; Matsubara N; Isozaki H; Takakura N; Horimi T; Tanaka N
J Int Med Res; 1999; 27(1):27-37. PubMed ID: 10417959
[TBL] [Abstract][Full Text] [Related]
12. Survival Benefit of Radiofrequency Ablation with Intratumoral Cisplatin Administration in a Rabbit VX2 Lung Tumor Model.
Murai K; Hamamoto S; Okuma T; Kageyama K; Yamamoto A; Ogawa S; Nota T; Sohgawa E; Jogo A; Miki Y
Cardiovasc Intervent Radiol; 2021 Mar; 44(3):475-481. PubMed ID: 33165680
[TBL] [Abstract][Full Text] [Related]
13. Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.
Yamakawa Y; Tazawa H; Hasei J; Osaki S; Omori T; Sugiu K; Komatsubara T; Uotani K; Fujiwara T; Yoshida A; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
Cancer Sci; 2017 Sep; 108(9):1870-1880. PubMed ID: 28685948
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4.
Ahmed SU; Okamoto M; Oshikawa T; Tano T; Sasai A; Kan S; Hiroshima T; Ohue H; Moriya Y; Ryoma Y; Saito M; Sato M
J Immunother; 2004; 27(6):432-41. PubMed ID: 15534487
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.
Erös de Bethlenfalva-Hora C; Mertens JC; Piguet AC; Kettenbach J; Schmitt J; Terracciano L; Weimann R; Dufour JF; Geier A
Clin Sci (Lond); 2014 Feb; 126(3):243-52. PubMed ID: 23822114
[TBL] [Abstract][Full Text] [Related]
16. Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.
Behm B; Di Fazio P; Michl P; Neureiter D; Kemmerling R; Hahn EG; Strobel D; Gress T; Schuppan D; Wissniowski TT
Gut; 2016 Jan; 65(1):134-43. PubMed ID: 25524262
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of mouse natural killer cell activity by combined hyperthermia and streptococcal preparation, OK-432 (Picibanil) treatment.
Taradi M; Urano M; Taradi SK; Maruyama Y
Int J Hyperthermia; 1991; 7(4):653-65. PubMed ID: 1919160
[TBL] [Abstract][Full Text] [Related]
18. TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis.
Xu A; Zhang L; Yuan J; Babikr F; Freywald A; Chibbar R; Moser M; Zhang W; Zhang B; Fu Z; Xiang J
Cell Mol Immunol; 2019 Oct; 16(10):820-832. PubMed ID: 30467420
[TBL] [Abstract][Full Text] [Related]
19. Mild microwave ablation combined with HSP90 and TGF‑β1 inhibitors enhances the therapeutic effect on osteosarcoma.
Chen L; Wang M; Lin Z; Yao M; Wang W; Cheng S; Li B; Zhang Y; Yin Q
Mol Med Rep; 2020 Aug; 22(2):906-914. PubMed ID: 32468060
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness evaluation of dendritic cell immunotherapy for osteosarcoma on survival rate and in vitro immune response.
Fang X; Jiang C; Xia Q
Genet Mol Res; 2015 Oct; 14(4):11763-70. PubMed ID: 26436501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
